{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T06:01:15Z","timestamp":1793772075847,"version":"4.6.1"},"reference-count":200,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2022,11,6]],"date-time":"2022-11-06T00:00:00Z","timestamp":1667692800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biology"],"abstract":"<jats:p>Non-alcoholic fatty liver disease (NAFLD) is a prevalent, multifactorial, and poorly understood liver disease with an increasing incidence worldwide. NAFLD is typically asymptomatic and coupled with other symptoms of metabolic syndrome. The prevalence of NAFLD is rising in tandem with the prevalence of obesity. In the Western hemisphere, NAFLD is one of the most prevalent causes of liver disease and liver transplantation. Recent research suggests that gut microbiome dysbiosis may play a significant role in the pathogenesis of NAFLD by dysregulating the gut\u2013liver axis. The so-called \u201cgut\u2013liver axis\u201d refers to the communication and feedback loop between the digestive system and the liver. Several pathological mechanisms characterized the alteration of the gut\u2013liver axis, such as the impairment of the gut barrier and the increase of the intestinal permeability which result in endotoxemia and inflammation, and changes in bile acid profiles and metabolite levels produced by the gut microbiome. This review will explore the role of gut\u2013liver axis disruption, mediated by gut microbiome dysbiosis, on NAFLD development.<\/jats:p>","DOI":"10.3390\/biology11111622","type":"journal-article","created":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T02:43:51Z","timestamp":1667789031000},"page":"1622","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":68,"title":["Gut\u2013Liver Axis and Non-Alcoholic Fatty Liver Disease: A Vicious Circle of Dysfunctions Orchestrated by the Gut Microbiome"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5751-9263","authenticated-orcid":false,"given":"Salvatore","family":"Pezzino","sequence":"first","affiliation":[{"name":"Department of Surgical Sciences and Advanced Technologies \u201cG. F. Ingrassia\u201d, Cannizzaro Hospital, University of Catania, 95126 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Sofia","sequence":"additional","affiliation":[{"name":"Department of Surgical Sciences and Advanced Technologies \u201cG. F. Ingrassia\u201d, Cannizzaro Hospital, University of Catania, 95126 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Faletra","sequence":"additional","affiliation":[{"name":"Department of Surgical Sciences and Advanced Technologies \u201cG. F. Ingrassia\u201d, Cannizzaro Hospital, University of Catania, 95126 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4406-6592","authenticated-orcid":false,"given":"Chiara","family":"Mazzone","sequence":"additional","affiliation":[{"name":"Department of Surgical Sciences and Advanced Technologies \u201cG. F. Ingrassia\u201d, Cannizzaro Hospital, University of Catania, 95126 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Litrico","sequence":"additional","affiliation":[{"name":"Department of Surgical Sciences and Advanced Technologies \u201cG. F. Ingrassia\u201d, Cannizzaro Hospital, University of Catania, 95126 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"La Greca","sequence":"additional","affiliation":[{"name":"Department of Surgical Sciences and Advanced Technologies \u201cG. F. Ingrassia\u201d, Cannizzaro Hospital, University of Catania, 95126 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saverio","family":"Latteri","sequence":"additional","affiliation":[{"name":"Department of Surgical Sciences and Advanced Technologies \u201cG. F. Ingrassia\u201d, Cannizzaro Hospital, University of Catania, 95126 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,11,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1042\/BCJ20160510","article-title":"Introduction to the Human Gut Microbiota","volume":"474","author":"Thursby","year":"2017","journal-title":"Biochem. J."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/nature09944","article-title":"Enterotypes of the Human Gut Microbiome","volume":"473","author":"Arumugam","year":"2011","journal-title":"Nature"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/nature11234","article-title":"Human Microbiome Project Consortium Structure, Function and Diversity of the Healthy Human Microbiome","volume":"486","author":"Huttenhower","year":"2012","journal-title":"Nature"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jcmgh.2019.07.006","article-title":"The Structure and Function of the Human Small Intestinal Microbiota: Current Understanding and Future Directions","volume":"9","author":"Kastl","year":"2020","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41367-019-0011-7","article-title":"Gut Microbiota: A New Path to Treat Obesity","volume":"9","author":"Muscogiuri","year":"2019","journal-title":"Int. J. Obes. Supp."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"100030","DOI":"10.1016\/j.sipas.2021.100030","article-title":"Gut Microbiota in Obesity and Nonalcoholic Fatty Liver Disease","volume":"5","author":"Guo","year":"2021","journal-title":"Surg. Pract. Sci."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Pouwels, S., Sakran, N., Graham, Y., Leal, A., Pintar, T., Yang, W., Kassir, R., Singhal, R., Mahawar, K., and Ramnarain, D. (2022). Non-Alcoholic Fatty Liver Disease (NAFLD): A Review of Pathophysiology, Clinical Management and Effects of Weight Loss. BMC Endocr. Disord., 22.","DOI":"10.1186\/s12902-022-00980-1"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/s41422-020-0332-7","article-title":"Interaction between Microbiota and Immunity in Health and Disease","volume":"30","author":"Zheng","year":"2020","journal-title":"Cell Res."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Yoo, J.Y., Groer, M., Dutra, S.V.O., Sarkar, A., and McSkimming, D.I. (2020). Gut Microbiota and Immune System Interactions. Microorganisms, 8.","DOI":"10.3390\/microorganisms8101587"},{"key":"ref_10","unstructured":"Kalra, A., Yetiskul, E., Wehrle, C.J., and Tuma, F. (2022). Physiology, Liver. StatPearls, StatPearls Publishing."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/B978-0-12-370491-7.00014-3","article-title":"Gastrointestinal Function","volume":"14","author":"Hornbuckle","year":"2008","journal-title":"Clin. Biochem. Domest. Anim."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/MPG.0b013e318284abb5","article-title":"Microbiota and gut-liver axis: A mini-review on their influences on obesity and obesity related liver disease","volume":"56","author":"Vajro","year":"2013","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S2468-1253(21)00020-0","article-title":"Non-Alcoholic Fatty Liver Disease: A Multisystem Disease Requiring a Multidisciplinary and Holistic Approach","volume":"6","author":"Targher","year":"2021","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","article-title":"NAFLD: A Multisystem Disease","volume":"62","author":"Byrne","year":"2015","journal-title":"J. Hepatol."},{"key":"ref_15","first-page":"404","article-title":"Epidemiology of Nonalcoholic Fatty Liver Disease in Europe: A Systematic Review and Meta-Analysis","volume":"34","author":"Cholongitas","year":"2021","journal-title":"Ann. Gastroenterol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"610","DOI":"10.7150\/ijbs.29599","article-title":"Obesity, Nonalcoholic Fatty Liver Disease and Adipocytokines Network in Promotion of Cancer","volume":"15","author":"Divella","year":"2019","journal-title":"Int. J. Biol. Sci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/liv.13299","article-title":"The Epidemiology of Non-Alcoholic Fatty Liver Disease","volume":"37","author":"Bellentani","year":"2017","journal-title":"Liver Int."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1210\/endrev\/bnz009","article-title":"Nonalcoholic Fatty Liver Disease in Adults: Current Concepts in Etiology, Outcomes, and Management","volume":"41","author":"Marjot","year":"2020","journal-title":"Endocr. Rev."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jhep.2019.10.003","article-title":"The Gut-Liver Axis in Liver Disease: Pathophysiological Basis for Therapy","volume":"72","author":"Albillos","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Song, Q., and Zhang, X. (2022). The Role of Gut\u2013Liver Axis in Gut Microbiome Dysbiosis Associated NAFLD and NAFLD-HCC. Biomedicines, 10.","DOI":"10.3390\/biomedicines10030524"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"110","DOI":"10.4291\/wjgp.v6.i4.110","article-title":"New-Found Link between Microbiota and Obesity","volume":"6","author":"Chakraborti","year":"2015","journal-title":"World J. Gastrointest. Pathophysiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.bbadis.2018.06.023","article-title":"Animal Models of NAFLD from a Hepatologist\u2019s Point of View","volume":"1865","author":"Jahn","year":"2019","journal-title":"Biochim. Biophys. Acta (BBA) Mol. Basis Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1136\/gutjnl-2019-319664","article-title":"Dietary Cholesterol Drives Fatty Liver-Associated Liver Cancer by Modulating Gut Microbiota and Metabolites","volume":"70","author":"Zhang","year":"2021","journal-title":"Gut"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"11710","DOI":"10.1021\/acs.jafc.0c02570","article-title":"High-Fat Proteins Drive Dynamic Changes in Gut Microbiota, Hepatic Metabolome, and Endotoxemia-TLR-4-NF\u03baB-Mediated Inflammation in Mice","volume":"68","author":"Ahmad","year":"2020","journal-title":"J. Agric. Food Chem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1900487","DOI":"10.1002\/mnfr.201900487","article-title":"A Network Involving Gut Microbiota, Circulating Bile Acids, and Hepatic Metabolism Genes That Protects against Non-Alcoholic Fatty Liver Disease","volume":"63","author":"Petrov","year":"2019","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Gart, E., Souto Lima, E., Schuren, F., de Ruiter, C.G.F., Attema, J., Verschuren, L., Keijer, J., Salic, K., Morrison, M.C., and Kleemann, R. (2018). Diet-Independent Correlations between Bacteria and Dysfunction of Gut, Adipose Tissue, and Liver: A Comprehensive Microbiota Analysis in Feces and Mucosa of the Ileum and Colon in Obese Mice with NAFLD. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20010001"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/s41467-017-00796-x","article-title":"Gastric Acid Suppression Promotes Alcoholic Liver Disease by Inducing Overgrowth of Intestinal Enterococcus","volume":"8","author":"Llorente","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"12200","DOI":"10.1038\/s41598-017-11744-6","article-title":"Lack of NLRP3-Inflammasome Leads to Gut-Liver Axis Derangement, Gut Dysbiosis and a Worsened Phenotype in a Mouse Model of NAFLD","volume":"7","author":"Pierantonelli","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/nature05414","article-title":"An Obesity-Associated Gut Microbiome with Increased Capacity for Energy Harvest","volume":"444","author":"Turnbaugh","year":"2006","journal-title":"Nature"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1136\/gutjnl-2012-303816","article-title":"Intestinal Microbiota Determines Development of Non-Alcoholic Fatty Liver Disease in Mice","volume":"62","author":"Llopis","year":"2013","journal-title":"Gut"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1096\/fj.14-259515","article-title":"Commensal Microbiota Is Hepatoprotective and Prevents Liver Fibrosis in Mice","volume":"29","author":"Mazagova","year":"2015","journal-title":"FASEB J."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1002\/oby.20330","article-title":"Bifidobacterium CECT 7765 Improves Metabolic and Immunological Alterations Associated with Obesity in High-Fat Diet-Fed Mice","volume":"21","author":"Cano","year":"2013","journal-title":"Obesity (Silver Spring)"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S1499-3872(17)60019-5","article-title":"Gut Microbiota Dysbiosis in Patients with Non-Alcoholic Fatty Liver Disease","volume":"16","author":"Shen","year":"2017","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41575-020-0269-9","article-title":"Gut Microbiota and Human NAFLD: Disentangling Microbial Signatures from Metabolic Disorders","volume":"17","author":"Vigliotti","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1080\/19490976.2019.1681861","article-title":"Lower Gut Microbiome Diversity and Higher Abundance of Proinflammatory Genus Collinsella Are Associated with Biopsy-Proven Nonalcoholic Steatohepatitis","volume":"11","author":"Astbury","year":"2020","journal-title":"Gut Microbes"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/s41598-020-79718-9","article-title":"Microbiota Analysis and Transient Elastography Reveal New Extra-Hepatic Components of Liver Steatosis and Fibrosis in Obese Patients","volume":"11","author":"Lanthier","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Vallianou, N., Christodoulatos, G.S., Karampela, I., Tsilingiris, D., Magkos, F., Stratigou, T., Kounatidis, D., and Dalamaga, M. (2021). Understanding the Role of the Gut Microbiome and Microbial Metabolites in Non-Alcoholic Fatty Liver Disease: Current Evidence and Perspectives. Biomolecules, 12.","DOI":"10.3390\/biom12010056"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/hep.28356","article-title":"The Severity of Nonalcoholic Fatty Liver Disease Is Associated with Gut Dysbiosis and Shift in the Metabolic Function of the Gut Microbiota","volume":"63","author":"Boursier","year":"2016","journal-title":"Hepatology"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Tsai, M.-C., Liu, Y.-Y., Lin, C.-C., Wang, C.-C., Wu, Y.-J., Yong, C.-C., Chen, K.-D., Chuah, S.-K., Yao, C.-C., and Huang, P.-Y. (2020). Gut Microbiota Dysbiosis in Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study in Taiwan. Nutrients, 12.","DOI":"10.3390\/nu12030820"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Wong, V.W.-S., Tse, C.-H., Lam, T.T.-Y., Wong, G.L.-H., Chim, A.M.-L., Chu, W.C.-W., Yeung, D.K.-W., Law, P.T.-W., Kwan, H.-S., and Yu, J. (2013). Molecular Characterization of the Fecal Microbiota in Patients with Nonalcoholic Steatohepatitis\u2014A Longitudinal Study. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0062885"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.cgh.2013.02.015","article-title":"Fecal Microbiome and Volatile Organic Compound Metabolome in Obese Humans with Nonalcoholic Fatty Liver Disease","volume":"11","author":"Raman","year":"2013","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/hep.26319","article-title":"Intestinal Microbiota in Patients with Nonalcoholic Fatty Liver Disease","volume":"58","author":"Mouzaki","year":"2013","journal-title":"Hepatology"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12944-021-01440-w","article-title":"Compositional Alterations of Gut Microbiota in Nonalcoholic Fatty Liver Disease Patients: A Systematic Review and Meta-Analysis","volume":"20","author":"Li","year":"2021","journal-title":"Lipids Health Dis."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3389\/fmicb.2020.00219","article-title":"Function of Akkermansia Muciniphila in Obesity: Interactions with Lipid Metabolism, Immune Response and Gut Systems","volume":"11","author":"Xu","year":"2020","journal-title":"Front. Microbiol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1053\/j.gastro.2009.01.073","article-title":"Helicobacter Pylori in Health and Disease","volume":"136","author":"Cover","year":"2009","journal-title":"Gastroenterology"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"619","DOI":"10.2147\/DMSO.S237866","article-title":"Relationship between Helicobacter Pylori Infection and Nonalcoholic Fatty Liver Disease (NAFLD) in a Developing Country: A Cross-Sectional Study","volume":"13","author":"Sabal","year":"2020","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/MCG.0000000000000784","article-title":"Helicobacter Pylori and Risk of Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis","volume":"52","author":"Wijarnpreecha","year":"2018","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Magne, F., Gotteland, M., Gauthier, L., Zazueta, A., Pesoa, S., Navarrete, P., and Balamurugan, R. (2020). The Firmicutes\/Bacteroidetes Ratio: A Relevant Marker of Gut Dysbiosis in Obese Patients?. Nutrients, 12.","DOI":"10.3390\/nu12051474"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13098-020-00570-y","article-title":"NAFLD as a Continuum: From Obesity to Metabolic Syndrome and Diabetes","volume":"12","author":"Valerio","year":"2020","journal-title":"Diabetol. Metab. Syndr."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"32002","DOI":"10.1038\/srep32002","article-title":"Altered Fecal Microbiota Correlates with Liver Biochemistry in Nonobese Patients with Non-Alcoholic Fatty Liver Disease","volume":"6","author":"Wang","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1007\/s11695-021-05867-z","article-title":"Trends of Overweight and Obesity in Male Adolescents: Prevalence, Socioeconomic Status, and Impact on Cardiovascular Risk in a Central European Country","volume":"32","author":"Gensthaler","year":"2022","journal-title":"Obes. Surg."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s40273-014-0243-x","article-title":"The Epidemiology of Obesity: A Big Picture","volume":"33","author":"Hruby","year":"2015","journal-title":"PharmacoEconomics"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.3389\/fendo.2021.706978","article-title":"Obesity: Epidemiology, Pathophysiology, and Therapeutics","volume":"12","author":"Lin","year":"2021","journal-title":"Front. Endocrinol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"365","DOI":"10.4082\/kjfm.20.0165","article-title":"Sedentary Lifestyle: Overview of Updated Evidence of Potential Health Risks","volume":"41","author":"Park","year":"2020","journal-title":"Korean J. Fam. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"11070","DOI":"10.1073\/pnas.0504978102","article-title":"Obesity Alters Gut Microbial Ecology","volume":"102","author":"Ley","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1136\/gut.2010.215665","article-title":"Composition and Energy Harvesting Capacity of the Gut Microbiota: Relationship to Diet, Obesity and Time in Mouse Models","volume":"59","author":"Murphy","year":"2010","journal-title":"Gut"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s42523-019-0007-1","article-title":"Impaired Glucose Metabolism and Altered Gut Microbiome despite Calorie Restriction of Ob\/Ob Mice","volume":"1","author":"Kashani","year":"2019","journal-title":"Anim. Microbiome"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Kasai, C., Sugimoto, K., Moritani, I., Tanaka, J., Oya, Y., Inoue, H., Tameda, M., Shiraki, K., Ito, M., and Takei, Y. (2015). Comparison of the Gut Microbiota Composition between Obese and Non-Obese Individuals in a Japanese Population, as Analyzed by Terminal Restriction Fragment Length Polymorphism and next-Generation Sequencing. BMC Gastroenterol., 15.","DOI":"10.1186\/s12876-015-0330-2"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1089\/chi.2018.0040","article-title":"Childhood Obesity and Firmicutes\/Bacteroidetes Ratio in the Gut Microbiota: A Systematic Review","volume":"14","author":"Indiani","year":"2018","journal-title":"Child. Obes."},{"key":"ref_60","first-page":"308","article-title":"The Human Gut Microbiota: Metabolism and Perspective in Obesity","volume":"9","author":"Gomes","year":"2018","journal-title":"Gut Microbes"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/s41430-020-0607-6","article-title":"Profile of the Gut Microbiota of Adults with Obesity: A Systematic Review","volume":"74","author":"Crovesy","year":"2020","journal-title":"Eur. J. Clin. Nutr."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"5532","DOI":"10.1038\/s41598-021-84928-w","article-title":"Gut Microbiota Markers Associated with Obesity and Overweight in Italian Adults","volume":"11","author":"Palmas","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/oby.2009.167","article-title":"Microbiota and SCFA in Lean and Overweight Healthy Subjects","volume":"18","author":"Schwiertz","year":"2010","journal-title":"Obesity"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/ijo.2008.155","article-title":"Human Colonic Microbiota Associated with Diet, Obesity and Weight Loss","volume":"32","author":"Duncan","year":"2008","journal-title":"Int. J. Obes."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3164\/jcbn.15-152","article-title":"Comparison of the Gut Microbial Community between Obese and Lean Peoples Using 16S Gene Sequencing in a Japanese Population","volume":"59","author":"Andoh","year":"2016","journal-title":"J. Clin. Biochem. Nutr."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1038\/nutd.2011.8","article-title":"The Metabolic Activity of Gut Microbiota in Obese Children Is Increased Compared with Normal-Weight Children and Exhibits More Exhaustive Substrate Utilization","volume":"1","author":"Payne","year":"2011","journal-title":"Nutr. Diabetes"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Pinart, M., D\u00f6tsch, A., Schlicht, K., Laudes, M., Bouwman, J., Forslund, S.K., Pischon, T., and Nimptsch, K. (2021). Gut Microbiome Composition in Obese and Non-Obese Persons: A Systematic Review and Meta-Analysis. Nutrients, 14.","DOI":"10.3390\/nu14010012"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"a029314","DOI":"10.1101\/cshperspect.a029314","article-title":"Cell Biology of Tight Junction Barrier Regulation and Mucosal Disease","volume":"10","author":"Buckley","year":"2018","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1002\/hep.22848","article-title":"Increased Intestinal Permeability and Tight Junction Alterations in Nonalcoholic Fatty Liver Disease","volume":"49","author":"Miele","year":"2009","journal-title":"Hepatology"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.dld.2014.02.010","article-title":"Intestinal Permeability Is Increased in Children with Non-Alcoholic Fatty Liver Disease, and Correlates with Liver Disease Severity","volume":"46","author":"Giorgio","year":"2014","journal-title":"Dig. Liver Dis."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"279","DOI":"10.4161\/gmic.19625","article-title":"Involvement of Gut Microbiota in the Development of Low-Grade Inflammation and Type 2 Diabetes Associated with Obesity","volume":"3","author":"Cani","year":"2012","journal-title":"Gut Microbes"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"G518","DOI":"10.1152\/ajpgi.00024.2006","article-title":"Increased Intestinal Permeability in Obese Mice: New Evidence in the Pathogenesis of Nonalcoholic Steatohepatitis","volume":"292","author":"Brun","year":"2007","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1084\/jem.20071416","article-title":"JAM-A Regulates Permeability and Inflammation in the Intestine in Vivo","volume":"204","author":"Laukoetter","year":"2007","journal-title":"J. Exp. Med."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1053\/j.gastro.2008.04.002","article-title":"Unique Role of Junctional Adhesion Molecule-A in Maintaining Mucosal Homeostasis in Inflammatory Bowel Disease","volume":"135","author":"Vetrano","year":"2008","journal-title":"Gastroenterology"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/mi.2010.5","article-title":"Multiple Facets of Intestinal Permeability and Epithelial Handling of Dietary Antigens","volume":"3","author":"Heyman","year":"2010","journal-title":"Mucosal Immunol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1091\/mbc.e13-06-0298","article-title":"JAM-A Associates with ZO-2, Afadin, and PDZ-GEF1 to Activate Rap2c and Regulate Epithelial Barrier Function","volume":"24","author":"Monteiro","year":"2013","journal-title":"MBoC"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1053\/j.gastro.2016.06.022","article-title":"Loss of Junctional Adhesion Molecule A Promotes Severe Steatohepatitis in Mice on a Diet High in Saturated Fat, Fructose, and Cholesterol","volume":"151","author":"Rahman","year":"2016","journal-title":"Gastroenterology"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.lfs.2018.08.017","article-title":"Gut Inflammation Exacerbates Hepatic Injury in the High-Fat Diet Induced NAFLD Mouse: Attention to the Gut-Vascular Barrier Dysfunction","volume":"209","author":"Cheng","year":"2018","journal-title":"Life Sci."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"756299","DOI":"10.3389\/fmicb.2021.756299","article-title":"Dextran Sulfate Sodium Salt-Induced Colitis Aggravates Gut Microbiota Dysbiosis and Liver Injury in Mice With Non-Alcoholic Steatohepatitis","volume":"12","author":"Shen","year":"2021","journal-title":"Front. Microbiol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"4814","DOI":"10.3748\/wjg.v25.i33.4814","article-title":"Intestinal Permeability in the Pathogenesis of Liver Damage: From Non-Alcoholic Fatty Liver Disease to Liver Transplantation","volume":"25","author":"Nicoletti","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"8096","DOI":"10.1038\/srep08096","article-title":"Dysbiosis Gut Microbiota Associated with Inflammation and Impaired Mucosal Immune Function in Intestine of Humans with Non-Alcoholic Fatty Liver Disease","volume":"5","author":"Jiang","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1111\/liv.14696","article-title":"Intestinal Permeability in Human Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis","volume":"40","author":"Xu","year":"2020","journal-title":"Liver Int."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"4999","DOI":"10.4049\/jimmunol.1402598","article-title":"Lipopolysaccharide Regulation of Intestinal Tight Junction Permeability Is Mediated by TLR4 Signal Transduction Pathway Activation of FAK and MyD88","volume":"195","author":"Guo","year":"2015","journal-title":"J. Immunol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.bbadis.2012.10.006","article-title":"Focal Adhesion Kinase Regulates Intestinal Epithelial Barrier Function via Redistribution of Tight Junction","volume":"1832","author":"Ma","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"e1251384","DOI":"10.1080\/21688370.2016.1251384","article-title":"Zonulin, a Regulator of Epithelial and Endothelial Barrier Functions, and Its Involvement in Chronic Inflammatory Diseases","volume":"4","author":"Sturgeon","year":"2016","journal-title":"Tissue Barriers"},{"key":"ref_86","first-page":"674106","article-title":"Gut Microbiota, Microinflammation, Metabolic Profile, and Zonulin Concentration in Obese and Normal Weight Subjects","volume":"2013","author":"Aptekorz","year":"2013","journal-title":"Int. J. Endocrinol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"17107","DOI":"10.3748\/wjg.v20.i45.17107","article-title":"Increased Circulating Zonulin in Children with Biopsy-Proven Nonalcoholic Fatty Liver Disease","volume":"20","author":"Pacifico","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"377","DOI":"10.5152\/tjg.2017.17084","article-title":"Effects of Long-Term Synbiotic Supplementation in Addition to Lifestyle Changes in Children with Obesity-Related Non-Alcoholic Fatty Liver Disease","volume":"28","author":"Kaya","year":"2017","journal-title":"Turk. J. Gastroenterol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1089\/ars.2018.7596","article-title":"Does Nox2 Overactivate in Children with Nonalcoholic Fatty Liver Disease?","volume":"30","author":"Loffredo","year":"2019","journal-title":"Antioxid. Redox Signal."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"704","DOI":"10.20452\/pamw.2558","article-title":"A Composite Model Including Visfatin, Tissue Polypeptide-Specific Antigen, Hyaluronic Acid, and Hematological Variables for the Diagnosis of Moderate-to-Severe Fibrosis in Nonalcoholic Fatty Liver Disease: A Preliminary Study","volume":"124","author":"Chwist","year":"2014","journal-title":"Pol. Arch. Intern. Med."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1134\/S1990750821030069","article-title":"Haptoglobin as a Biomarker","volume":"15","author":"Naryzny","year":"2021","journal-title":"Biochem. Moscow Suppl. Ser. B"},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Kamada, Y., Akita, M., Takeda, Y., Yamada, S., Fujii, H., Sawai, Y., Doi, Y., Asazawa, H., Nakayama, K., and Mizutani, K. (2013). Serum Fucosylated Haptoglobin as a Novel Diagnostic Biomarker for Predicting Hepatocyte Ballooning and Nonalcoholic Steatohepatitis. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0066328"},{"key":"ref_93","first-page":"1451","article-title":"Lipopolysaccharide Biogenesis and Transport at the Outer Membrane of Gram-Negative Bacteria","volume":"1862","author":"Sperandeo","year":"2017","journal-title":"Biochim. Biophys. Acta (BBA) Mol. Cell Biol. Lipids"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/labinvest.2014.11","article-title":"Metabolically Induced Liver Inflammation Leads to NASH and Differs from LPS- or IL-1\u03b2-Induced Chronic Inflammation","volume":"94","author":"Liang","year":"2014","journal-title":"Lab. Investig."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"41434","DOI":"10.18632\/oncotarget.5163","article-title":"LPS-Induced TNF-\u03b1 Factor Mediates pro-Inflammatory and pro-Fibrogenic Pattern in Non-Alcoholic Fatty Liver Disease","volume":"6","author":"Ceccarelli","year":"2015","journal-title":"Oncotarget"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.4049\/jimmunol.1500130","article-title":"Subclinical Dose Endotoxin Sustains Low-Grade Inflammation and Exacerbates Steatohepatitis in High-Fat Diet Fed Mice","volume":"196","author":"Guo","year":"2016","journal-title":"J. Immunol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.jhep.2011.02.035","article-title":"DSS Induced Colitis Increases Portal LPS Levels and Enhances Hepatic Inflammation and Fibrogenesis in Experimental NASH","volume":"55","author":"Dostert","year":"2011","journal-title":"J. Hepatol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1476-9255-7-15","article-title":"Elevated Endotoxin Levels in Non-Alcoholic Fatty Liver Disease","volume":"7","author":"Harte","year":"2010","journal-title":"J. Inflamm."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"770986","DOI":"10.3389\/fendo.2021.770986","article-title":"Endotoxins and Non-Alcoholic Fatty Liver Disease","volume":"12","author":"Kessoku","year":"2021","journal-title":"Front. Endocrinol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.phrs.2019.01.026","article-title":"Intestinally Derived Bacterial Products Stimulate Development of Nonalcoholic Steatohepatitis","volume":"141","author":"Dornas","year":"2019","journal-title":"Pharmacol. Res."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3164\/jcbn.13-49","article-title":"Lipopolysaccharides Accelerate Hepatic Steatosis in the Development of Nonalcoholic Fatty Liver Disease in Zucker Rats","volume":"54","author":"Fukunishi","year":"2014","journal-title":"J. Clin. Biochem. Nutr."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s11605-021-05188-7","article-title":"The Role of Gut-Derived Lipopolysaccharides and the Intestinal Barrier in Fatty Liver Diseases","volume":"26","author":"An","year":"2022","journal-title":"J. Gastrointest. Surg."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"7563","DOI":"10.3748\/wjg.v27.i43.7563","article-title":"Immunoglobulin G in Non-Alcoholic Steatohepatitis Predicts Clinical Outcome: A Prospective Multi-Centre Cohort Study","volume":"27","author":"Lamba","year":"2021","journal-title":"World J. Gastroenterol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S0952-7915(97)80152-5","article-title":"Innate Immunity: Impact on the Adaptive Immune Response","volume":"9","author":"Medzhitov","year":"1997","journal-title":"Curr. Opin. Immunol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/intimm\/dxp017","article-title":"The Roles of TLRs, RLRs and NLRs in Pathogen Recognition","volume":"21","author":"Kawai","year":"2009","journal-title":"Int. Immunol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3389\/fimmu.2014.00461","article-title":"Toll-Like Receptor Signaling Pathways","volume":"5","author":"Kawasaki","year":"2014","journal-title":"Front. Immunol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"7381","DOI":"10.3748\/wjg.v20.i23.7381","article-title":"Role of Gut Microbiota and Toll-like Receptors in Nonalcoholic Fatty Liver Disease","volume":"20","author":"Miura","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.jhep.2007.04.019","article-title":"Toll-like Receptor-4 Signaling and Kupffer Cells Play Pivotal Roles in the Pathogenesis of Non-Alcoholic Steatohepatitis","volume":"47","author":"Rivera","year":"2007","journal-title":"J. Hepatol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/MPG.0b013e3181c7bdf1","article-title":"Endotoxin and Plasminogen Activator Inhibitor-1 Serum Levels Associated with Nonalcoholic Steatohepatitis in Children","volume":"50","author":"Alisi","year":"2010","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/jgh.13058","article-title":"Small Intestinal Bacterial Overgrowth and Toll-like Receptor Signaling in Patients with Non-Alcoholic Fatty Liver Disease","volume":"31","author":"Kapil","year":"2016","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"G270","DOI":"10.1152\/ajpgi.00304.2014","article-title":"Hepatic TLR4 Signaling in Obese NAFLD","volume":"309","author":"Sharifnia","year":"2015","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.molmet.2018.05.015","article-title":"Hepatocyte Toll-like Receptor 4 Deficiency Protects against Alcohol-Induced Fatty Liver Disease","volume":"14","author":"Jia","year":"2018","journal-title":"Mol. Metab."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1136\/gut.2008.156307","article-title":"Toll-like Receptors as Targets in Chronic Liver Diseases","volume":"58","author":"Mencin","year":"2009","journal-title":"Gut"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1755-1536-3-21","article-title":"Toll-like Receptor 4 Signaling in Liver Injury and Hepatic Fibrogenesis","volume":"3","author":"Guo","year":"2010","journal-title":"Fibrogenesis Tissue Repair"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s12072-010-9219-x","article-title":"The Role of Lipopolysaccharide\/Toll-like Receptor 4 Signaling in Chronic Liver Diseases","volume":"4","author":"Soares","year":"2010","journal-title":"Hepatol. Int."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"749125","DOI":"10.3389\/fendo.2021.749125","article-title":"Gut Microbiota in Adipose Tissue Dysfunction Induced Cardiovascular Disease: Role as a Metabolic Organ","volume":"12","author":"Yang","year":"2021","journal-title":"Front. Endocrinol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.cmet.2015.07.026","article-title":"Crosstalk between Gut Microbiota and Dietary Lipids Aggravates WAT Inflammation through TLR Signaling","volume":"22","author":"Caesar","year":"2015","journal-title":"Cell Metab."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3389\/fcvm.2020.00022","article-title":"Adipose Tissue Distribution, Inflammation and Its Metabolic Consequences, Including Diabetes and Cardiovascular Disease","volume":"7","author":"Chait","year":"2020","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_119","first-page":"682","article-title":"The NLRP3 Inflammasome in Non-Alcoholic Fatty Liver Disease and Steatohepatitis: Therapeutic Targets and Treatment","volume":"13","author":"Yu","year":"2022","journal-title":"Front. Pharmacol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"644333","DOI":"10.3389\/fmed.2021.644333","article-title":"Interplay Between Microbiota, Toll-Like Receptors and Cytokines for the Maintenance of Epithelial Barrier Integrity","volume":"8","author":"Semin","year":"2021","journal-title":"Front. Med."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1007\/s00109-014-1170-1","article-title":"NLRP3 Inflammasome Activation Is Required for Fibrosis Development in NAFLD","volume":"92","author":"Wree","year":"2014","journal-title":"J. Mol. Med."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.jhep.2017.01.022","article-title":"NLRP3 Inflammasome Blockade Reduces Liver Inflammation and Fibrosis in Experimental NASH in Mice","volume":"66","author":"Mridha","year":"2017","journal-title":"J. Hepatol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"448","DOI":"10.3389\/fmed.2020.00448","article-title":"Non-Alcoholic Fatty Liver Disease and Alcohol-Related Liver Disease: Two Intertwined Entities","volume":"7","author":"Idalsoaga","year":"2020","journal-title":"Front. Med."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"567654","DOI":"10.3389\/fmicb.2020.567654","article-title":"Microbial Metabolites: Critical Regulators in NAFLD","volume":"11","author":"Dai","year":"2020","journal-title":"Front. Microbiol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3389\/fmicb.2016.00047","article-title":"Ethanol Production by Selected Intestinal Microorganisms and Lactic Acid Bacteria Growing under Different Nutritional Conditions","volume":"7","author":"Elshaghabee","year":"2016","journal-title":"Front. Microbiol."},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Baker, S.S., Baker, R.D., Liu, W., Nowak, N.J., and Zhu, L. (2010). Role of Alcohol Metabolism in Non-Alcoholic Steatohepatitis. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0009570"},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Park, E., Jeong, J.-J., Won, S.-M., Sharma, S.P., Gebru, Y.A., Ganesan, R., Gupta, H., Suk, K.T., and Kim, D.J. (2021). Gut Microbiota-Related Cellular and Molecular Mechanisms in the Progression of Nonalcoholic Fatty Liver Disease. Cells, 10.","DOI":"10.3390\/cells10102634"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.cmet.2019.08.018","article-title":"Fatty Liver Disease Caused by High-Alcohol-Producing Klebsiella Pneumoniae","volume":"30","author":"Yuan","year":"2019","journal-title":"Cell Metab."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/01.NT.0000286155.55343.fa","article-title":"Choline: Dietary Requirements and Role in Brain Development","volume":"42","author":"Sanders","year":"2007","journal-title":"Nutr. Today"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.bbalip.2011.09.009","article-title":"Phosphatidylcholine Biosynthesis and Lipoprotein Metabolism","volume":"1821","author":"Cole","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/j.bbamem.2017.04.006","article-title":"The Critical Role of Phosphatidylcholine and Phosphatidylethanolamine Metabolism in Health and Disease","volume":"1859","author":"Kennelly","year":"2017","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/MOL.0b013e3282fee935","article-title":"Role of Phosphatidylcholine Biosynthesis in the Regulation of Lipoprotein Homeostasis","volume":"19","author":"Vance","year":"2008","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_133","doi-asserted-by":"crossref","unstructured":"Van Herck, M.A., Vonghia, L., and Francque, S.M. (2017). Animal Models of Nonalcoholic Fatty Liver Disease\u2014A Starter\u2019s Guide. Nutrients, 9.","DOI":"10.3390\/nu9101072"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1177\/0148607101025005260","article-title":"Choline Deficiency Causes Reversible Hepatic Abnormalities in Patients Receiving Parenteral Nutrition: Proof of a Human Choline Requirement: A Placebo-Controlled Trial","volume":"25","author":"Buchman","year":"2001","journal-title":"JPEN J. Parenter. Enteral. Nutr."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.3945\/jn.114.197533","article-title":"Higher Dietary Choline Intake Is Associated with Lower Risk of Nonalcoholic Fatty Liver in Normal-Weight Chinese Women12","volume":"144","author":"Yu","year":"2014","journal-title":"J. Nutr."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1016\/S0021-9258(18)69166-5","article-title":"The Active Synthesis of Phosphatidylcholine Is Required for Very Low Density Lipoprotein Secretion from Rat Hepatocytes","volume":"263","author":"Yao","year":"1988","journal-title":"J. Biol. Chem."},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"Huang, J.-K., and Lee, H.-C. (2022). Emerging Evidence of Pathological Roles of Very-Low-Density Lipoprotein (VLDL). Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23084300"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1139\/o90-079","article-title":"Reduction in VLDL, but Not HDL, in Plasma of Rats Deficient in Choline","volume":"68","author":"Yao","year":"1990","journal-title":"Biochem. Cell Biol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3727\/105221617X15093707969658","article-title":"Updates on Dietary Models of Nonalcoholic Fatty Liver Disease: Current Studies and Insights","volume":"18","author":"Stephenson","year":"2018","journal-title":"Gene Expr."},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"Soret, P.-A., Magusto, J., Housset, C., and Gautheron, J. (2021). In Vitro and In Vivo Models of Non-Alcoholic Fatty Liver Disease: A Critical Appraisal. J. Clin. Med., 10.","DOI":"10.3390\/jcm10010036"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature09922","article-title":"Gut Flora Metabolism of Phosphatidylcholine Promotes Cardiovascular Disease","volume":"472","author":"Wang","year":"2011","journal-title":"Nature"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1053\/j.gastro.2010.11.049","article-title":"Association Between Composition of the Human Gastrointestinal Microbiome and Development of Fatty Liver with Choline Deficiency","volume":"140","author":"Spencer","year":"2011","journal-title":"Gastroenterology"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"12511","DOI":"10.1073\/pnas.0601056103","article-title":"Metabolic Profiling Reveals a Contribution of Gut Microbiota to Fatty Liver Phenotype in Insulin-Resistant Mice","volume":"103","author":"Dumas","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"892","DOI":"10.3945\/ajcn.111.020156","article-title":"Choline Intake in a Large Cohort of Patients with Nonalcoholic Fatty Liver Disease123","volume":"95","author":"Guerrerio","year":"2012","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_145","doi-asserted-by":"crossref","unstructured":"Chang, T.-Y., Wu, C.-H., Chang, C.-Y., Lee, F.-J., Wang, B.-W., Doong, J.-Y., Lin, Y.-S., Kuo, C.-S., and Huang, R.-F.S. (2022). Optimal Dietary Intake Composition of Choline and Betaine Is Associated with Minimized Visceral Obesity-Related Hepatic Steatosis in a Case-Control Study. Nutrients, 14.","DOI":"10.3390\/nu14020261"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.bbalip.2012.08.009","article-title":"Phosphatidylcholine Biosynthesis and Function in Bacteria","volume":"1831","author":"Geiger","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0163-7827(02)00050-4","article-title":"Biosynthesis of Phosphatidylcholine in Bacteria","volume":"42","author":"Sohlenkamp","year":"2003","journal-title":"Prog. Lipid Res."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.bbadis.2014.02.012","article-title":"Role of Adipose Tissue in Methionine\u2013Choline-Deficient Model of Non-Alcoholic Steatohepatitis (NASH)","volume":"1842","author":"Jha","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_149","doi-asserted-by":"crossref","unstructured":"Arias, N., Arboleya, S., Allison, J., Kaliszewska, A., Higarza, S.G., Gueimonde, M., and Arias, J.L. (2020). The Relationship between Choline Bioavailability from Diet, Intestinal Microbiota Composition, and Its Modulation of Human Diseases. Nutrients, 12.","DOI":"10.3390\/nu12082340"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"4634172","DOI":"10.1155\/2020\/4634172","article-title":"Trimethylamine N-Oxide Generated by the Gut Microbiota Is Associated with Vascular Inflammation: New Insights into Atherosclerosis","volume":"2020","author":"Liu","year":"2020","journal-title":"Mediat. Inflamm."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1136\/gutjnl-2015-310283","article-title":"Microbiota-Induced Obesity Requires Farnesoid X Receptor","volume":"66","author":"Sommer","year":"2017","journal-title":"Gut"},{"key":"ref_152","doi-asserted-by":"crossref","unstructured":"Krueger, E.S., Lloyd, T.S., and Tessem, J.S. (2021). The Accumulation and Molecular Effects of Trimethylamine N-Oxide on Metabolic Tissues: It\u2019s Not All Bad. Nutrients, 13.","DOI":"10.3390\/nu13082873"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1111\/liv.14963","article-title":"Circulating Trimethylamine-N-Oxide Is Associated with All-Cause Mortality in Subjects with Nonalcoholic Fatty Liver Disease","volume":"41","author":"Post","year":"2021","journal-title":"Liver Int."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1002\/cphy.c120023","article-title":"Bile Acid Metabolism and Signaling","volume":"3","author":"Chiang","year":"2013","journal-title":"Compr. Physiol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"s4","DOI":"10.5604\/01.3001.0010.5493","article-title":"Bile Acid Physiology","volume":"16","author":"Garruti","year":"2017","journal-title":"Ann. Hepatol."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1631\/jzus.B1400327","article-title":"Cross-Talk between Bile Acids and Intestinal Microbiota in Host Metabolism and Health","volume":"16","author":"Nie","year":"2015","journal-title":"J. Zhejiang Univ. Sci. B"},{"key":"ref_157","doi-asserted-by":"crossref","unstructured":"Kiriyama, Y., and Nochi, H. (2022). Physiological Role of Bile Acids Modified by the Gut Microbiome. Microorganisms, 10.","DOI":"10.3390\/microorganisms10010068"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1159\/000282091","article-title":"Bile Acids as Regulators of Hepatic Lipid and Glucose Metabolism","volume":"28","author":"Trauner","year":"2010","journal-title":"Dig. Dis."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"R85","DOI":"10.1530\/JOE-15-0469","article-title":"The Role of Bile Acids in Metabolic Regulation","volume":"228","year":"2016","journal-title":"J. Endocrinol."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1194\/jlr.M075143","article-title":"Comprehensive Evaluation of the Bactericidal Activities of Free Bile Acids in the Large Intestine of Humans and Rodents","volume":"58","author":"Watanabe","year":"2017","journal-title":"J. Lipid Res."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s40168-021-01101-1","article-title":"Review: Microbial Transformations of Human Bile Acids","volume":"9","author":"Guzior","year":"2021","journal-title":"Microbiome"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"154457","DOI":"10.1016\/j.metabol.2020.154457","article-title":"Bile Acids Profile, Histopathological Indices and Genetic Variants for Non-Alcoholic Fatty Liver Disease Progression","volume":"116","author":"Nimer","year":"2021","journal-title":"Metabolism"},{"key":"ref_163","doi-asserted-by":"crossref","unstructured":"Fujii, H., Doi, H., Ko, T., Fukuma, T., Kadono, T., Asaeda, K., Kobayashi, R., Nakano, T., Doi, T., and Nakatsugawa, Y. (2020). Frequently Abnormal Serum Gamma-Glutamyl Transferase Activity Is Associated with Future Development of Fatty Liver: A Retrospective Cohort Study. BMC Gastroenterol., 20.","DOI":"10.1186\/s12876-020-01369-x"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/apt.15035","article-title":"Serum Bile Acid Patterns Are Associated with the Presence of NAFLD in Twins, and Dose-Dependent Changes with Increase in Fibrosis Stage in Patients with Biopsy-Proven NAFLD","volume":"49","author":"Caussy","year":"2019","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"3814","DOI":"10.1021\/acs.jproteome.1c00104","article-title":"Serum Bile Acid Profiles Improve Clinical Prediction of Nonalcoholic Fatty Liver in T2DM Patients","volume":"20","author":"Wu","year":"2021","journal-title":"J. Proteome Res."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3727\/105221618X15156018385515","article-title":"Bile Acid Metabolism in Liver Pathobiology","volume":"18","author":"Chiang","year":"2018","journal-title":"Gene Expr."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.mam.2013.05.001","article-title":"Biosynthesis and Trafficking of the Bile Salt Export Pump, BSEP: Therapeutic Implications of BSEP Mutations","volume":"37","author":"Soroka","year":"2014","journal-title":"Mol. Asp. Med."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1097\/CM9.0000000000002156","article-title":"Bile Acids and Sphingolipids in Non-Alcoholic Fatty Liver Disease","volume":"135","author":"Jackson","year":"2022","journal-title":"Chin. Med. J."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.5604\/01.3001.0010.5494","article-title":"The Role of Bile Acids in Glucose Metabolism and Their Relation with Diabetes","volume":"16","author":"Uribe","year":"2017","journal-title":"Ann. Hepatol."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1053\/j.gastro.2017.01.055","article-title":"Bile Acid Control of Metabolism and Inflammation in Obesity, Type 2 Diabetes, Dyslipidemia, and Nonalcoholic Fatty Liver Disease","volume":"152","author":"Tailleux","year":"2017","journal-title":"Gastroenterology"},{"key":"ref_171","doi-asserted-by":"crossref","unstructured":"Mori, H., Svegliati Baroni, G., Marzioni, M., Di Nicola, F., Santori, P., Maroni, L., Abenavoli, L., and Scarpellini, E. (2022). Farnesoid X Receptor, Bile Acid Metabolism, and Gut Microbiota. Metabolites, 12.","DOI":"10.3390\/metabo12070647"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"257","DOI":"10.4093\/dmj.2019.0043","article-title":"Understanding Bile Acid Signaling in Diabetes: From Pathophysiology to Therapeutic Targets","volume":"43","author":"Ferrell","year":"2019","journal-title":"Diabetes Metab. J."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2174\/1568008054863781","article-title":"Role of FXR in Regulating Bile Acid Homeostasis and Relevance for Human Diseases","volume":"5","author":"Rizzo","year":"2005","journal-title":"Curr. Drug Targets Immune Endocr. Metab. Disord."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.livres.2020.05.001","article-title":"Up to Date on Cholesterol 7 Alpha-Hydroxylase (CYP7A1) in Bile Acid Synthesis","volume":"4","author":"Chiang","year":"2020","journal-title":"Liver Res."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/aps.2014.116","article-title":"Farnesoid X Receptor: A Master Regulator of Hepatic Triglyceride and Glucose Homeostasis","volume":"36","author":"Jiao","year":"2015","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000324126","article-title":"The Bile Acid Membrane Receptor TGR5: A Valuable Metabolic Target","volume":"29","author":"Pols","year":"2011","journal-title":"Dig. Dis."},{"key":"ref_177","doi-asserted-by":"crossref","unstructured":"Lou, G., Ma, X., Fu, X., Meng, Z., Zhang, W., Wang, Y.-D., Van Ness, C., Yu, D., Xu, R., and Huang, W. (2014). GPBAR1\/TGR5 Mediates Bile Acid-Induced Cytokine Expression in Murine Kupffer Cells. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0093567"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/hep.21458","article-title":"The G-Protein Coupled Bile Salt Receptor TGR5 Is Expressed in Liver Sinusoidal Endothelial Cells","volume":"45","author":"Keitel","year":"2007","journal-title":"Hepatology"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cmet.2009.08.001","article-title":"TGR5-Mediated Bile Acid Sensing Controls Glucose Homeostasis","volume":"10","author":"Thomas","year":"2009","journal-title":"Cell Metab."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1038\/s41591-022-02016-6","article-title":"Microbiome-Derived Ethanol in Nonalcoholic Fatty Liver Disease","volume":"28","author":"Meijnikman","year":"2022","journal-title":"Nat. Med."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/B978-0-12-800100-4.00003-9","article-title":"The Role of Short-Chain Fatty Acids in Health and Disease","volume":"121","author":"Tan","year":"2014","journal-title":"Adv. Immunol."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"e55664","DOI":"10.15252\/embr.202255664","article-title":"Local and Systemic Effects of Microbiome-Derived Metabolites","volume":"23","author":"Spivak","year":"2022","journal-title":"EMBO Rep."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"e02566-18","DOI":"10.1128\/mBio.02566-18","article-title":"Dynamics of Human Gut Microbiota and Short-Chain Fatty Acids in Response to Dietary Interventions with Three Fermentable Fibers","volume":"10","author":"Baxter","year":"2019","journal-title":"mBio"},{"key":"ref_184","first-page":"185","article-title":"Intestinal Short Chain Fatty Acids and Their Link with Diet and Human Health","volume":"7","author":"Margolles","year":"2016","journal-title":"Front. Microbiol."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1194\/jlr.R067629","article-title":"Short- and Medium-Chain Fatty Acids in Energy Metabolism: The Cellular Perspective","volume":"57","author":"Wojtczak","year":"2016","journal-title":"J. Lipid Res."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.3389\/fphar.2019.01040","article-title":"Butyrate Improves the Metabolic Disorder and Gut Microbiome Dysbiosis in Mice Induced by a High-Fat Diet","volume":"10","author":"Gao","year":"2019","journal-title":"Front. Pharmacol."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2147\/DMSO.S338113","article-title":"The Association Between Fecal Short-Chain Fatty Acids, Gut Microbiota, and Visceral Fat in Monozygotic Twin Pairs","volume":"15","author":"Yin","year":"2022","journal-title":"DMSO"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1177\/2050640618804444","article-title":"Fecal SCFAs and SCFA-Producing Bacteria in Gut Microbiome of Human NAFLD as a Putative Link to Systemic T-Cell Activation and Advanced Disease","volume":"6","author":"Rau","year":"2018","journal-title":"United Eur. Gastroenterol. J."},{"key":"ref_189","first-page":"11","article-title":"Gut Microbiota and Their Metabolites in the Progression of Non-Alcoholic Fatty Liver Disease","volume":"7","author":"Zhou","year":"2021","journal-title":"Hepatoma Res."},{"key":"ref_190","doi-asserted-by":"crossref","unstructured":"He, J., Zhang, P., Shen, L., Niu, L., Tan, Y., Chen, L., Zhao, Y., Bai, L., Hao, X., and Li, X. (2020). Short-Chain Fatty Acids and Their Association with Signalling Pathways in Inflammation, Glucose and Lipid Metabolism. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21176356"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3389\/fimmu.2016.00028","article-title":"GPR41 and GPR43 in Obesity and Inflammation\u2009\u2013\u2009Protective or Causative?","volume":"7","author":"Ang","year":"2016","journal-title":"Front. Immunol."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"16767","DOI":"10.1073\/pnas.0808567105","article-title":"Effects of the Gut Microbiota on Host Adiposity Are Modulated by the Short-Chain Fatty-Acid Binding G Protein-Coupled Receptor, Gpr41","volume":"105","author":"Samuel","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"262","DOI":"10.4093\/dmj.2012.36.4.262","article-title":"GLP-1 Receptor Agonist and Non-Alcoholic Fatty Liver Disease","volume":"36","author":"Lee","year":"2012","journal-title":"Diabetes Metab. J."},{"key":"ref_194","first-page":"158900","article-title":"Effects of Short Chain Fatty Acids on Metabolic and Inflammatory Processes in Human Health","volume":"1866","year":"2021","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"e004147","DOI":"10.1136\/jitc-2021-004147","article-title":"Microbial Short-Chain Fatty Acids: A Strategy to Tune Adoptive T Cell Therapy","volume":"10","author":"Rangan","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"598","DOI":"10.3892\/etm.2022.11536","article-title":"A Potential Link between Plasma Short-Chain Fatty Acids, TNF-\u03b1 Level and Disease Progression in Non-Alcoholic Fatty Liver Disease: A Retrospective Study","volume":"24","author":"Xiong","year":"2022","journal-title":"Exp. Ther. Med."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","article-title":"Global Epidemiology of NAFLD-Related HCC: Trends, Predictions, Risk Factors and Prevention","volume":"18","author":"Huang","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/hep.29466","article-title":"Modeling the Epidemic of Nonalcoholic Fatty Liver Disease Demonstrates an Exponential Increase in Burden of Disease","volume":"67","author":"Estes","year":"2018","journal-title":"Hepatology"},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"6911","DOI":"10.3748\/wjg.v19.i40.6911","article-title":"Effects of Probiotics on Nonalcoholic Fatty Liver Disease: A Meta-Analysis","volume":"19","author":"Ma","year":"2013","journal-title":"World J. Gastroenterol."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/jgh.15729","article-title":"New Perspective on Fecal Microbiota Transplantation in Liver Diseases","volume":"37","author":"Suk","year":"2022","journal-title":"J. Gastroenterol. Hepatol."}],"container-title":["Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-7737\/11\/11\/1622\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:11:29Z","timestamp":1760145089000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-7737\/11\/11\/1622"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,6]]},"references-count":200,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,11]]}},"alternative-id":["biology11111622"],"URL":"https:\/\/doi.org\/10.3390\/biology11111622","relation":{},"ISSN":["2079-7737"],"issn-type":[{"value":"2079-7737","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,6]]}}}